124 related articles for article (PubMed ID: 16488116)
1. Relative toxicities and neuromuscular nicotinic receptor agonistic potencies of anabasine enantiomers and anabaseine.
Lee ST; Wildeboer K; Panter KE; Kem WR; Gardner DR; Molyneux RJ; Chang CW; Soti F; Pfister JA
Neurotoxicol Teratol; 2006; 28(2):220-8. PubMed ID: 16488116
[TBL] [Abstract][Full Text] [Related]
2. Activation and Desensitization of Peripheral Muscle and Neuronal Nicotinic Acetylcholine Receptors by Selected, Naturally-Occurring Pyridine Alkaloids.
Green BT; Lee ST; Welch KD; Cook D; Kem WR
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27384586
[TBL] [Abstract][Full Text] [Related]
3. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
Kem WR; Mahnir VM; Papke RL; Lingle CJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
[TBL] [Abstract][Full Text] [Related]
4. Actions of piperidine alkaloid teratogens at fetal nicotinic acetylcholine receptors.
Green BT; Lee ST; Panter KE; Welch KD; Cook D; Pfister JA; Kem WR
Neurotoxicol Teratol; 2010; 32(3):383-90. PubMed ID: 20116429
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective potencies and relative toxicities of γ-coniceine and N-methylconiine enantiomers.
Lee ST; Green BT; Welch KD; Jordan GT; Zhang Q; Panter KE; Hughes D; Chang CW; Pfister JA; Gardner DR
Chem Res Toxicol; 2013 Apr; 26(4):616-21. PubMed ID: 23514442
[TBL] [Abstract][Full Text] [Related]
6. A Pharmacological Comparison of Two Isomeric Nicotinic Receptor Agonists: The Marine Toxin Isoanatabine and the Tobacco Alkaloid Anatabine.
Xing H; Keshwah S; Rouchaud A; Kem WR
Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32053997
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the Possible Pharmacologically Active Forms of the Nicotinic Acetylcholine Receptor Agonist Anabaseine.
Andrud K; Xing H; Gabrielsen B; Bloom L; Mahnir V; Lee S; Green BT; Lindstrom J; Kem W
Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31671780
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
de Fiebre CM; Meyer EM; Henry JC; Muraskin SI; Kem WR; Papke RL
Mol Pharmacol; 1995 Jan; 47(1):164-71. PubMed ID: 7838125
[TBL] [Abstract][Full Text] [Related]
9. Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.
Matera C; Quadri M; Sciaccaluga M; Pomè DY; Fasoli F; De Amici M; Fucile S; Gotti C; Dallanoce C; Grazioso G
Eur J Med Chem; 2016 Jan; 108():392-405. PubMed ID: 26706350
[TBL] [Abstract][Full Text] [Related]
10. Complete inhibition of fetal movement in the day 40 pregnant goat model by the piperidine alkaloid anabasine but not related alkaloids.
Green BT; Lee ST; Keele JW; Welch KD; Cook D; Pfister JA; Kem WR
Toxicon; 2018 Mar; 144():61-67. PubMed ID: 29452148
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs.
Kombo DC; Mazurov AA; Chewning J; Hammond PS; Tallapragada K; Hauser TA; Speake J; Yohannes D; Caldwell WS
Bioorg Med Chem Lett; 2012 Jan; 22(2):1179-86. PubMed ID: 22177081
[TBL] [Abstract][Full Text] [Related]
12. The role of the α7 subunit of the nicotinic acetylcholine receptor on motor coordination in mice treated with methyllycaconitine and anabasine.
Welch KD; Pfister JA; Gardner DR; Green BT; Panter KE
J Appl Toxicol; 2013 Sep; 33(9):1017-26. PubMed ID: 23702881
[TBL] [Abstract][Full Text] [Related]
13. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.
Stevens KE; Kem WR; Mahnir VM; Freedman R
Psychopharmacology (Berl); 1998 Apr; 136(4):320-7. PubMed ID: 9600576
[TBL] [Abstract][Full Text] [Related]
14. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia.
Mastropaolo J; Rosse RB; Deutsch SI
Behav Brain Res; 2004 Aug; 153(2):419-22. PubMed ID: 15265637
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
Meyer EM; Kuryatov A; Gerzanich V; Lindstrom J; Papke RL
J Pharmacol Exp Ther; 1998 Dec; 287(3):918-25. PubMed ID: 9864273
[TBL] [Abstract][Full Text] [Related]
16. Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.
Kombo DC; Mazurov A; Tallapragada K; Hammond PS; Chewning J; Hauser TA; Vasquez-Valdivieso M; Yohannes D; Talley TT; Taylor P; Caldwell WS
Eur J Med Chem; 2011 Nov; 46(11):5625-35. PubMed ID: 21986237
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective potencies and relative toxicities of coniine enantiomers.
Lee ST; Green BT; Welch KD; Pfister JA; Panter KE
Chem Res Toxicol; 2008 Oct; 21(10):2061-4. PubMed ID: 18763813
[TBL] [Abstract][Full Text] [Related]
18. Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor.
Machu TK; Hamilton ME; Frye TF; Shanklin CL; Harris MC; Sun H; Tenner TE; Soti FS; Kem WR
J Pharmacol Exp Ther; 2001 Dec; 299(3):1112-9. PubMed ID: 11714901
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist.
Kem WR
Invert Neurosci; 1997; 3(2-3):251-9. PubMed ID: 9783447
[TBL] [Abstract][Full Text] [Related]
20. Discovery of the Nicotinic Receptor Toxin Anabaseine in a
Kem WR; Rocca JR; Johnson JV; Junoy J
Toxins (Basel); 2023 Jan; 15(1):. PubMed ID: 36668866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
